Possibilities and limitations for reversal of age-related hair loss

Aging Hair

Volumn , Issue , 2010, Pages 193-205

  Otberg, Nina ^a,b   Restrepo, Isabel ^c   Shapiro, Jerry ^a,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Skin and Laser Center Potsdam   (Germany)

^c UNIVERSIDAD CES   (Colombia)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869173691     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-02636-2_18     Document Type: Chapter

References (96)

1. Alajlan A, Shapiro J, Rivers JK et al (2005) Paradoxical hypertrichosis after laser epilation. J Am Acad Dermatol 53:85-88
2. Amory JK, Wang C, Swerdloff RS et al (2007) the effect of 5alpha reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endocrinol Metab 92:1659-1665
3. Anderson BE, Mackley CL, Helm KF (2003) Alopecia mucinosa: report of a case and review. J Cutan Med Surg 7:124-128
4. Arca E, Kose O, Tastan HB et al (2004) Follicular mucinosis responding to isotretinoin treatment. J Dermatol Treat 15:391-395
5. Avram MR, Leonard RT, Epstein ES et al (2007) The current role of laser light sources in the treatment of male and female pattern hair loss. J Cosmet Laser Ther 9:27-28
6. Barman JM, Astore I, Pecoraro V (1965) The normal trichogram of the adult. J Invest Dermatol 44:233-236
7. Bianchi L, Paro Vidolin A, Piemonte P, Carboni I, Chimenti S (2001) Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A. Clin Exp Dermatol 26:518-520
8. Birch MP, Messenger JF, Messenger AG (2001) Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 144:297-304
9. Bolduc C, Shapiro J (2000) Management of androgenetic alopecia. Am J Clin Dermatol 1:151-158
10. Bouzari N, Firooz AR (2006) Laser may induce terminal terminal hair growth. Dermatol Surg 32:460
11. Brenner S, Matz H (1999) Improvement in androgenetic alopecia in 53-76 year old men using oral finasteride. Int J Dermatol 38:928-930
12. Buhl AE, Waldon DJ, Baker CA et al (1990) Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol 95:553-557
13. Carey AH, Waterworth D, Patel K et al (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873-1876
14. Chieregato C, Zini A, Barba A et al (2003) Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol 74:784-786
15. Chumlea WC, Rhodes T, Girman CJ et al (2004) Family history and risk of hair loss. Dermatology 209:33-39
16. Clark RV, Hermann DJ, Cunningham GR et al (2004) Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5-alphareductase inhibitor. J Clin Endocrinol Metab 89:2179-2184
17. Courtois M, Loussouarn G, Hourseau C et al (1995) Ageing and hair cycles. Br J Dermatol 132:86-93
18. D'Amico AV, Roehrborn CG (2007) Effect 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenetic alopecia: a randomized controlled trial. Lancet Oncol 8:21-25
19. Dooley TP, Walker CJ, Hirshey SJ et al (1991) Localization of minoxidil sulfotransferase in rat liver and the outer root sheat of anagen pelage and vibrissa follicles. J Invest Dermatol 96:65-70
20. Draelos ZD (2006) Sunscreens and hair photoprotection. Dermatol Clin 24:81-84
21. Ellis JA, Stebbing M, Harrap SB (1998) Genetic analysis of male pattern baldness and the 5alpha-reductase genes. J Invest Dermatol 110:849-853
22. Ellis JA, Sinclair R, Harrap SB (2004) Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 4:1-11
23. Emmerson RW (1969) Follicular mucinosis. A study of 47 patients. Br J Dermatol 81:395
24. Friedman ES, Friedman PM, Cohen DE et al (2002) Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol 46:309-312
25. Galbrait GM, Thiers BH (1985) In vitro suppression of human lymphocyte by minoxidil. Int J Dermatol 24:249-251
26. Gibson LE, Muller SA, Peters MS (1988) Follicular mucinosis of childhood and adolescence. Pediatr Dermatol 5:231-235
27. Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann NY Acad Sci 53:708-728
28. Han JH, Kwon OS, Chung JH et al (2004) Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle. J Dermatol Sci 34:91-98
29. Harrison S, Sinclair R (2002) Telogen effluvium. Clin Exp Dermatol 27:389-385
30. Harthi FA, Kudwah A, Ajlan A et al (2003) Urticaria-like follicular mucinosis responding to dapsone. Acta Derm Venereol 83:389-390
31. Headington JT (1996) Cicatricial alopecia. Dermatol Clin 14:773-782
32. Headington JT, Novak E (1984) Clinical and histologic studies of male pattern hair baldness treated with topical minoxidil. Curr Ther Res 36:1098-1106
33. Hibberts NA, Howell AE, Randall VA (1998) Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 156:59-65
34. Hillmer AM, Brockschmidt FF, Hanneken S et al (2008) Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 40:1279-1281
35. Hoffman RM (1998) Topical liposome targeting of dyes, melanins, genes and proteins electively to hair follicle. J Drug Target 5:67-74
36. Hordinsky M, Sawaya M, Roberts JL (2002) Hair loss and hirsutism in the elderly. Clin Geriatr Med 18:121-133
37. Hordinsky MK, Wietgrefe MM, Sevenich E et al (1985) Immune function in alopecia areata patients applying 3% topical minoxidil. Clin Res 33:646A
38. Imperato-McGinley J (2002) 5alpha-reductase-2 deficiency and complete androgen insensitivity: lessons from nature. Adv Exp Med Biol 511:121-131
39. Iorizzo M, Vincenzi C, Voudouris S et al (2006) Finasteride treatment of female pattern hair loss. Arch Dermatol 142:298-302
40. Kaufman KD, Olsen EA, Whiting D et al (1998) Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 39:578-589
41. Kligman AM (1959) The human hair cycle. J Invest Dermatol 33:307-316
42. Kligman AM (1988) The comparative histopathology of male-pattern baldness and senescent baldness. Clin Dermatol 6:108-118
43. Kodama H, Umemura S, Nohara N (1988) Follicular mucinosis: response to indomethacin. J Dermatol 15:72-75
44. Lachgar S, Charveron M, Gall Y et al (1998) Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol 138:407-411
45. Leyden J, Dunlap F, Miller B et al (1999) Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 40:930-937
46. Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247
47. Meisheri KD, Cipkus LA, Taylor CJ (1988) Mechanism of action of minoxidil sulfate-induced vasodilation: a role for increased K+ permeability. J Pharmacol Exp Ther 245:751-760
48. Morton CC, Byers MG, Nakai H, Bell GI, Shows TB. Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22 - q24.1, 11p15 and 4q25 - q27, respectively. Cytogenet Cell Genet 1986:41(4):245-249
49. Mondaini N, Gontero P, Giubilei G et al (2007) Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med 4:1708-1712
50. Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J 68:1359-1365
51. Olsen E (1989) Treatment of androgenetic alopecia with topical minoxidil. Res Staff Phys 53:35
52. Olsen E, Stenn K, Bergfeld W et al (2003) Update on cicatricial alopecia. J Investig Dermatol Symp Proc 8:18-19
53. Olsen EA (1999) The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women. J Am Acad Dermatol 40:106-109
54. Olsen EA, Bergfeld WF, Cotsarelis G et al (2003) Summary of North American Hair Research Society (NAHRS) - sponsored workshop on Cicatricial Alopecia, Duke University Medical Center, 10 and 11 February 2001. J Am Acad Dermatol 48:103-110
55. Olsen EA, Hordinsky M, Whiting D et al (2006) The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol 55:1014-1023
56. Olszewska M, Rudnicka L (2005) Effective treatment of female androgenetic alopecia with dutasteride. J Drugs Dermatol 4:637-640
57. Otberg N, Finner AM, Shapiro J (2007) Androgenetic alopecia. Endocrinol Metab Clin North Am 36:379-398
58. Otberg N, Wu WY, McElwee KJ et al (2008) Diagnosis and management of primary cicatricial alopecia: part I. Skinmed 7:19-26
59. Overstreet JW, Fug VL, Gould J et al (1999) Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol 162:1295-1300
60. Passaro EM, Silveira MT, Valente NY (2004) Acneiform follicular mucinosis. Clin Exp Dermatol 29:396-398
61. Peluso AM, Misciali C, Vincenzi C et al (1997) Diffuse hypertrichosis during treatment with 5% topical minoxidil. Br J Dermatol 136:118-120
62. Price VH (1999) Treatment of hair loss. N Engl J Med 341:964-973
63. Price VH, Roberts JL, Hordinski M et al (2000) Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 43:768-776
64. Randall VA, Ebling FJ (1991) Seasonal changes in human hair growth. Br J Dermatol 124:146-151
65. Rhodes L, Harper J, Gaito H et al (1994) The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone in adult male and female stump-tail macaques (Macaca arctoides). J Clin Endocrinol Metab 29:291-296
66. Richards JB, Yuan X, Geller F et al (2008) Male-pattern baldness susceptibility locus at 20p11. Nat Genet 40:1282-1284
67. Roberts JL, Fiedler V, Imperato-McGinley J et al (1999) Clinical dose ranging studies with finasteride, a type 2 5-alpha reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol 41:555-563
68. Roehrborn CG, Boyle P, Nickel JC et al (2002) Efficacy and safety of dual inhibitor of 5alpha reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 60:434-441
69. Rundegren J (2004) Pattern alopecia: what clinical features determine the response to topical minoxidil treatment? JDDG 2:500
70. Rushton DH, Ramsay ID, Norris MJ et al (1991) Natural progression of male pattern baldness in young men. Clin Exp Dermatol 16:188-192
71. Safavi KH, Muller SA, Suman VJ et al (1995) Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 70:628-633
72. Sellheyer K, Bergfeld WF (2006) Histopathologic evaluation of alopecias. Am J Dermatopathol 28:236-259
73. Shapiro J (2007) Clinical practice. Hair loss in women. N Engl J Med 18:1620-1630
74. Shapiro J, Price VH (1998) Hair regrowth therapeutic agents. Dermatol Clin 16:341-356
75. Sinclair R, Grossman KL, Kvedar JC (2003) Anagen hair loss. McGraw-Hill, New York
76. Sperling LC, Lupton GP (1995) Histopathology of nonscarring alopecia. J Cutan Pathol: 97-114
77. Sperling LC, Solomon AR, Whiting DA (2000) A new look at scarring alopecia. Arch Dermatol 136:235-242
78. Tajima M, Hamada C, Arai T et al (2007) Characteristic features of Japanese women's hair with aging and with progressing hair loss. J Dermatol Sci 45:93-103
79. Thompson MI, Goodman PJ, Tangen CM et al (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215-224
80. Tolgyesi E (1983) Weathering of hair. Cosmet Toilet 98:29-33
81. Tosti A, Iorizzo M, Piraccini BM (2005) Androgenetic alopecia in children: report of 20 cases. Br J Dermatol 152:556-559
82. Trueeb RM (2004) Finasteride treatment of patterned hair loss in normoandrogenetic postmenopausal women. Dermatology 209:202-207
83. Trueeb RM (2005) Aging of hair. J Cosm Derm 4:60-72
84. Unger WP, Unger RH (2003) Hair transplanting: An important but often forgotten treatment for female pattern hair loss. J Am Acad Dermatol 49:853-860
85. Uno H (1986) The stump-tailed macaque as a model for baldness: effects of minoxidil. Int J Cosmet Sci 8:63-71
86. Van Doorn R, Scheffer E, Willemze R (2002) Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. Arch Dermatol 138:191-198
87. Von Kobyletzki G, Kreuter JA, Nordmeier R et al (2000) Treatment of idiopathic mucinosis follicularis with UVA1 cold light phototherapy. Dermatology 201:76-77
88. Weiss VC, West DP (1985) Topical minoxidil therapy and hair regrowth. Arch Dermatol 121:191-192
89. Wester RC, Maibach HI, Guy RH et al (1984) Minoxidil stimulates cutaneous blood flow in human balding scalp: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol 82:515-517
90. Whiting DA (1996) Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 35:899-906
91. Whiting DA (2001) Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies Eur J Dermatol 11:332-334
92. Whiting DA (2003) Histopathologic features of alopecia areata: a new look. Arch Dermatol 139:1555-1559
93. Whiting DA, Waldstreicher J, Sanchez M et al (1999) Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: result of finasteride 1 mg treatment of men and postmenopausal women. J Invest Dermatol Symp Proc 4:282-284
94. Whiting DA, Olsen EA, Savin R et al (2003) Efficacy and tolerability of finasteride 1 mg in men aged 41-60 years with male pattern hair loss. Eur J Dermatol 13:150-160
95. Wu WY, Otberg N, McElwee KJ et al (2008) Diagnosis and management of primary cicatricial alopecia: part II. Skinmed 7:78-83
96. York J, Nicholson T, Minors P et al (1998) Stressful life events and loss of hair among adult women, a case-control study. Psychol Rep 82:1044-1046